Ketogenic diet in Indian children with uncontrolled epilepsy

J K Nathan1, A S Purandare, Z B Parekh

  • 1Department of Neurology, Shushrusha Hospital, Mumbai, India. jsvpnat@hotmail.com

Indian Pediatrics
|May 12, 2009
PubMed

Insights

The ketogenic diet is effective for controlling difficult epilepsy in Indian children. Epileptic encephalopathies showed better response to this diet compared to localization-related epilepsies.

Area of Science:

  • Pediatric Neurology
  • Metabolic Therapies
  • Epilepsy Management

Background:

  • Epilepsy is a common neurological disorder in children, often requiring multiple anti-seizure medications.
  • Uncontrolled epilepsy significantly impacts a child's quality of life and development.
  • The ketogenic diet is a high-fat, low-carbohydrate diet that has shown promise in managing refractory epilepsy.

Purpose of the Study:

  • To assess the efficacy of a ketogenic diet in Indian children with uncontrolled epilepsy.
  • To compare the diet's effectiveness in different epilepsy types: epileptic encephalopathies and localization-related epilepsies.

Main Methods:

  • A prospective observational study was conducted at a hospital.
  • 105 children (4 months to 18 years) with uncontrolled epilepsy were enrolled in a ketogenic diet program.
  • Seizure frequency reduction was the primary outcome measure, with follow-up for a median of 17 months.

Main Results:

  • 68 out of 105 children (65%) remained on the ketogenic diet.
  • 37% achieved 100% seizure control, and 22% achieved 90-99% control.
  • Epileptic encephalopathies demonstrated a more favorable response to the ketogenic diet than localization-related epilepsies.

Conclusions:

  • The Indian adaptation of the ketogenic diet is well-tolerated and effective for managing drug-resistant childhood epilepsy.
  • The ketogenic diet offers a viable therapeutic option for pediatric epilepsy in India.
  • Epileptic encephalopathies appear to benefit more significantly from ketogenic diet therapy.
Abstract

Related Concept Videos

Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...